Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Web Exclusives
FDA Updates
Pembrolizumab FDA Approved in Patients with Advanced Lung Cancer
Read More
FDA Updates
Nivolumab in Combination with Ipilimumab
Read More
Online First
Optimizing Care for Patients with Relapsed and/or Refractory Multiple Myeloma
Read More
Online First
Managing Adverse Events in the Late-line Setting for Multiple Myeloma
Laura McBride, RN, BSN, OCN, CCRP
Read More
Online First
Challenges in the Treatment of Relapsed and/or Refractory Myeloma
Timothy Tyler, PharmD, FCSHP
Read More
Online First
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Read More
Online First
Stakeholder’s Perspective: Pharmacy
Steven Stricker, PharmD, MS, BCOP
Read More
Online First
Stakeholder’s Perspective: Physician
Jeffrey A. Meyerhardt MD, MPH
Read More
Online First
Tumors More Heterogeneous Than Previously Recognized
Read More
Online First
CYP2D6 Genotyping Fails to Predict Effectiveness of Tamoxifen
Alice Goodman
Read More
33
34
35
36
37
38
39
Page 36 of 43
Results 351 - 360 of 425
